|
contents | europe | ||||
| BIO-Europe 2012 presenting companies offer preview of market innovation to VC and pharma investors The 18th annual BIO-Europe international partnering conference will be held in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. Europe's largest partnering conference attracts the world's top dealmakers from biotech, pharma and finance along with exciting emerging companies. The event, organized by EBD Group, the leading partnering firm for the life science industry, will highlight the biotech and pharmaceutical community in the Hamburg and Schleswig-Holstein life science sector and the BioRegion comprised of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Poland, Sweden, northern Germany and northwestern part of Russia. The high caliber of the conference program is exemplified by the Monday business development track entitled "New Pharma Strategies: Refining the R&D Blueprint" that features a powerful lineup of experts weighing in on the changing blueprint of R&D and commercialization strategies. The session will be moderated by George Schmidt of Campbell Alliance with panelists Philippe Lopes-Fernandes of Merck Serono; Anders Ekblom of AstraZeneca; and Garry Neil of the newly formed TransCelerate BioPharma collaborative. The presenting companies portion of the program gives venture capitalists and pharmaceutical companies a firsthand look at prominent new discovery pipelines taking shape in the market. There will be company presentations by emerging biotech companies, and many returning presenters such as 4SC AG; Addex Therapeutics; Ark Therapeutics; Cevec Pharmaceuticals GmbH; Curis Inc.; Medigene AG; and Scil Proteins GmbH. Another focus of the company presentations is on next generation companies from academic technology transfer and commercialization groups as well as innovative young companies including: Algiax Pharmaceuticals GmbH; DCPrime; GNA Biosolutions; Verapido / HSG-IMIT; Johns Hopkins School of Medicine; Macquarie University; PharmAbcine, Inc; Soluventis; UroTiss GmbH; Ciloa; Delenex Therapeutics AG; Toleranzia AB; STAT-Diagnostica & Innovation; BioScience Slovakia s.r.o.; Acesion Pharma; PSites Pharma GmbH; Novadiscovery; Jagiellonian University; Inositec; and Vaxdyn, SL. This year's event is being held in collaboration with Norgenta, known also as "Life Science Nord, " the service agency of Hamburg and the Federal State of Schleswig-Holstein, and ScanBalt fmba, the BioRegion association comprised of health and life science based sectors in the Nordic and Baltic countries. write your comments about the article :: © 2012 Exhibition News :: home page |